bf/NASDAQ:SAGE_icon.jpeg

COM:SAGERX

Sage Therapeutics

  • Stock

Last Close

4.91

21/11 21:00

Market Cap

663.81M

Beta: -

Volume Today

1.48M

Avg: -

  • locale

    usUnited States
  • market

    STOCKS
  • industry

    Biotechnology
  • website

    www.sagerx.com/
  • ipo date

    Jul 18, 2014

Sage Therapeutics, Inc., a biopharmaceutical company, develops and commercializes medicines to treat central nervous system disorders. Its lead product candidate is ZULRESSO, an intravenous formulation of brexanolone for the treatment of postpartum depression (PPD) in adults. The company's product pipeline also includes zuranolone, a neuroactive steroid, which is in Phase III c...Show More

competitor of